Showing posts with the label #nanomedicine

Nanorobots Attack Cancer

American-Chinese Scientists Collaborative Success in Fighting Cancer Medical Nanorobots Chinese and American scientists have successfully developed nanorobots using DNA origami that shrink cancer tumors by cutting off their blood supply.  The team includes scientists from Arizona State University and the National Center for Nanoscience and Technology of the Chinese Academy of Science. Tiny But Effective Therapy The nanorobots are composed of DNA origami which is 1000 times smaller than the width of a human hair.  DNA origami is expected to revolutionize medicine.  In this cancer breakthrough, a blood clotting enzyme is attached to the surface of the nanorobots.  In effect, this therapy cuts off the blood supply to the tumor, stopping its growth and leading to tumor tissue death. Nanomedicine First This is the first, fully autonomous DNA robotic system for targeted cancer therapy.  The nanorobots are programmed to attack cancer cells.  They did so within a few hours of injecti

Possilble Cure for Malaria Out of India

Researchers in India May Have Developed Medicine to Kill Malaria Hope for a Cure It's one of the worst and deadliest scourges impacting mankind.  Malaria afflicts 212 million people globally every year and causes 4.29 million deaths.  Until now it has been an intractable human disease.  But now there is hope. University of Hyderabad Scientists' New Medicine A group of scientists at the University of Hyderabad in India have developed a medicine that effectively kills the parasite infection in red blood cells that's triggered by malaria.  It's a polymer based nanomedicine developed by a research group led by Dr. Pradip Paik, Associate Professor of the School of Engineering and Technology at the University of Hyderabad in Telangana, India. Breakthrough Medicine Now Going into Animal Trials The medicine is very effective in killing the deadly malaria parasite, which triggers plasmodium falciparum infections in the body's red blood cells.  It's now going in